03/22/2024 3:01 PM | Denali Therapeutics (Filer)
| Form S-3ASR | |
03/01/2024 3:51 PM | Denali Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
02/27/2024 7:03 AM | Denali Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 7:07 AM | Denali Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2024 4:38 PM | Denali Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 4:38 PM | Denali Therapeutics (Issuer) SATO VICKI L (Reporting) SATO VICKI L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 7:02 AM | Denali Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
02/15/2024 8:14 PM | Denali Therapeutics (Issuer) Schuth Alexander O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 8:14 PM | Denali Therapeutics (Issuer) Ho Carole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 8:15 PM | Denali Therapeutics (Issuer) Watts Ryan J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 8:16 PM | Denali Therapeutics (Issuer) Krognes Steve E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:43 PM | Denali Therapeutics (Subject) Ho Carole (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 7:22 PM | Denali Therapeutics (Subject) Krognes Steve E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 7:17 PM | Denali Therapeutics (Subject) Watts Ryan J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 7:18 PM | Denali Therapeutics (Subject) Schuth Alexander O. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 7:19 PM | Denali Therapeutics (Subject) Ho Carole (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 6:07 PM | BIOGEN INC. (Filed by) Denali Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024 5:59 AM | BAILLIE GIFFORD & CO (Filed by) Denali Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024 5:40 AM | Denali Therapeutics (Subject) Temasek Holdings Ltd (0001021944) (Filed by)
| Form SC 13G/A | |
01/18/2024 5:26 PM | Denali Therapeutics (Issuer) SATO VICKI L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 3:23 PM | Denali Therapeutics (Subject) SATO VICKI L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 7:18 PM | Denali Therapeutics (Issuer) Ho Carole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 4:28 PM | Denali Therapeutics (Issuer) Watts Ryan J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 3:09 PM | Denali Therapeutics (Subject) Ho Carole (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024 6:34 PM | Denali Therapeutics (Issuer) Krognes Steve E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 6:35 PM | Denali Therapeutics (Issuer) Ho Carole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 6:33 PM | Denali Therapeutics (Issuer) Watts Ryan J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 6:34 PM | Denali Therapeutics (Issuer) Schuth Alexander O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 6:20 PM | Denali Therapeutics (Subject) Watts Ryan J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 7:06 AM | Denali Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2024 7:25 PM | Denali Therapeutics (Subject) Denali Therapeutics (Subject) Watts Ryan J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 7:27 PM | Denali Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 7:27 PM | Denali Therapeutics (Subject) Krognes Steve E. (Reporting) Krognes Steve E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 7:21 PM | Denali Therapeutics (Subject) Denali Therapeutics (Subject) Ho Carole (Reporting) Ho Carole (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 7:23 PM | Denali Therapeutics (Subject) Schuth Alexander O. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 4:57 PM | Denali Therapeutics (Issuer) Ho Carole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 4:57 PM | Denali Therapeutics (Issuer) Schuth Alexander O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 4:56 PM | Denali Therapeutics (Issuer) Watts Ryan J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 6:30 PM | Denali Therapeutics (Issuer) SATO VICKI L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 5:14 PM | Denali Therapeutics (Issuer) SATO VICKI L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 3:44 PM | Denali Therapeutics (Issuer) SATO VICKI L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
AI to Meet the Same Fate as EVs? (Ad) When these tech bubbles burst, they invariably leave investors disillusioned by their losses.
Now, many worry a similar fate is awaiting AI.
And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. |
10/16/2023 3:16 PM | Denali Therapeutics (Subject) SATO VICKI L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2023 4:06 PM | Cole Douglas G. (Reporting) Denali Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/05/2023 3:31 PM | Cole Douglas G. (Reporting) Denali Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2023 3:45 PM | Denali Therapeutics (Issuer) SATO VICKI L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/15/2023 4:26 PM | Denali Therapeutics (Subject) SATO VICKI L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/25/2023 4:30 PM | Denali Therapeutics (Issuer) Ho Carole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2023 4:36 PM | Denali Therapeutics (Issuer) Schuth Alexander O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 3:31 PM | Denali Therapeutics (Issuer) Krognes Steve E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 3:32 PM | Denali Therapeutics (Issuer) Watts Ryan J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 3:33 PM | Denali Therapeutics (Issuer) Schuth Alexander O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 3:34 PM | Denali Therapeutics (Issuer) Ho Carole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 1:41 PM | Denali Therapeutics (Subject) Watts Ryan J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023 1:43 PM | Denali Therapeutics (Subject) Krognes Steve E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023 1:45 PM | Denali Therapeutics (Subject) Ho Carole (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023 1:47 PM | Denali Therapeutics (Subject) Schuth Alexander O. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023 5:42 PM | Denali Therapeutics (Issuer) SATO VICKI L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2023 5:19 PM | Denali Therapeutics (Issuer) Schuth Alexander O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2023 5:20 PM | Denali Therapeutics (Issuer) Ho Carole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 3:34 PM | Denali Therapeutics (Subject) SATO VICKI L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 4:11 PM | Denali Therapeutics (Issuer) Schuth Alexander O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 4:12 PM | Denali Therapeutics (Issuer) Ho Carole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 4:13 PM | Denali Therapeutics (Issuer) Watts Ryan J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 1:44 PM | Denali Therapeutics (Subject) Ho Carole (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 1:45 PM | Denali Therapeutics (Subject) Schuth Alexander O. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2023 4:09 PM | Denali Therapeutics (Issuer) SATO VICKI L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2023 4:10 PM | Denali Therapeutics (Issuer) Schuth Alexander O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2023 3:12 PM | Denali Therapeutics (Subject) Schuth Alexander O. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023 3:40 PM | Denali Therapeutics (Subject) SATO VICKI L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2023 4:21 PM | Denali Therapeutics (Issuer) SATO VICKI L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2023 4:14 PM | Denali Therapeutics (Subject) SATO VICKI L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023 6:03 AM | Denali Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2023 4:37 PM | Denali Therapeutics (Subject) Watts Ryan J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023 4:59 PM | Denali Therapeutics (Issuer) SATO VICKI L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 5:01 PM | Cole Douglas G. (Reporting) Denali Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 5:02 PM | Denali Therapeutics (Issuer) Harris Erik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 5:03 PM | Denali Therapeutics (Issuer) FLATLEY JAY T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 5:04 PM | Denali Therapeutics (Issuer) Schenkein David P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 5:04 PM | Cook Jennifer E. (Reporting) Denali Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 5:05 PM | Denali Therapeutics (Issuer) Klein Peter S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 5:06 PM | Denali Therapeutics (Issuer) Tessier-Lavigne Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 5:07 PM | Denali Therapeutics (Issuer) Krognes Steve E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 5:08 PM | Denali Therapeutics (Issuer) Thornberry Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 7:12 AM | Denali Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2023 1:53 PM | Denali Therapeutics (Subject) Schuth Alexander O. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/24/2023 6:10 PM | Denali Therapeutics (Issuer) Watts Ryan J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/20/2023 4:08 PM | Denali Therapeutics (Subject) Watts Ryan J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/14/2023 5:27 PM | Denali Therapeutics (Issuer) Schuth Alexander O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/30/2023 5:14 AM | Denali Therapeutics (Subject) Temasek Holdings Ltd (0001021944) (Filed by)
| Form SC 13G | |